Showing results (141-150 of 320) with videos related to

Sort By:
Pageof 32
Chemical Science|May 17, 2017
An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity <i>in vivo</i>Josef Mayr, Petra Heffeter, Diana Groza, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 8, 2004
Whole genome amplification for CGH analysis: Linker-adapter PCR as the method of choice for difficult and limited samplesChristine Pirker, Maria Raidl, Elisabeth Steiner, et al.
Wiener Klinische Wochenschrift|November 4, 2017
Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfallsChristiane Thallinger, Thorsten Füreder, Matthias Preusser, et al.
Pathology Oncology Research : POR|March 10, 2015
Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS MutationsTamás Garay, Eszter Molnár, Éva Juhász, et al.
Frontiers in Chemistry|April 25, 2020
Magnetic Temperature-Sensitive Solid-Lipid Particles for Targeting and Killing Tumor CellsMałgorzata Świętek, Rostyslav Panchuk, Nadia Skorokhyd, et al.
Organometallics|February 23, 2013
Metal-Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular AccumulationLukas K Filak, Simone Göschl, Petra Heffeter, et al.
Angewandte Chemie (International Ed. in English)|December 28, 2020
Interaction with Ribosomal Proteins Accompanies Stress Induction of the Anticancer Metallodrug BOLD-100/KP1339 in the Endoplasmic ReticulumBenjamin Neuditschko, Anton A Legin, Dina Baier, et al.
Metallomics : Integrated Biometal Science|September 10, 2019
Preclinical studies on metal based anticancer drugs as enabled by integrated metallomics and metabolomicsLuis Galvez, Mate Rusz, Michaela Schwaiger-Haber, et al.
Journal of Inorganic Biochemistry|November 2, 2018
Synthesis and biological evaluation of biotin-conjugated anticancer thiosemicarbazones and their iron(III) and copper(II) complexesSebastian Kallus, Lukas Uhlik, Sushilla van Schoonhoven, et al.
Molecular Carcinogenesis|April 11, 2014
Canine and human sarcomas exhibit predominant FGFR1 expression and impaired viability after inhibition of signalingNicole Schweiger, Marlene Hauck, Heinrich Steinhoff, et al.
Pageof 32